Trypanosomosis is a widespread and important disease of animals and humans in tsetseinfested areas of Africa, Nigeria inclusive. To investigate the comparative effects of graded doses of Diaminazine aceturate (DA) and fixed doses of Levamisole in the treatment of albino mice experimentally infected with field isolates of Trypanosoma brucei brucei. Thirty adult mice were used and were randomly divided into 6 groups of 5 mice each. After infection has been established, 3 groups (A, B and C) were treated with graded doses of DA at 7, 14 and 21mg/kg body weight respectively and a fixed dose of Levamisole at 7.5mg/kg body weight, whereas group D was treated with Levamisole only at the same dose. Group E served as positive (infected untreated) control while group F served a negative (uninfected untreated) control. The following parameters were used to access the efficacy of the drugs: weekly rectal temperature, weight changes, packed cell volume, haemoglobin concentration, clinical signs or survivability and parasitaemia. The parasite cleared from groups A, B and C by the 48 th hour post treatment, but remained in group D while all the mice in group E died within 65 days PI, those in group D died within 65 days PI, whereas those in Group D died within 35 days post treatment. Relapse infection was only recorded in group A at day 30 post treatment. There was no relapse in group B and C, but more deaths were recorded in group C. The significant reduction (p<0.05) in the weight, PCV and haemoglobin concentration and an increase in rectal temperature following infection was reversed by the treatments in groups A, B and C. The results obtained show that an increased dose of DA at 14mg/kg body weight and Levamisole at 7.5mg/kg body weight proved most effective in the treatment of clinical cases of infection with Trypanosoma brucei brucei.
INTRODUCTION
Trypanosomosis is a widespread and important disease of animals and humans in tsetse-infested areas of Africa (PAAT, 2001; Shaw 2004) . Trypanosomosis is a serious infective disease caused by various species of the haemoflagellate protozoa, called Trypanosomes. They multiply in the blood, lymph, various organs and tissues of the host and they are transmitted mainly by different species of tsetse fly of the genus Glossina (Herbert, 1991; Anene et al., 2001) . Trypanosomiasis causes complex public health and epizootic problems in many developing countries in Africa (Bacchi et al., 2009 ). Trypanososmosis coupled with inadequate management practices, hamper the productive husbandry of these animals (Nwosu et al., 2007) . If these infected animals are left untreated animals may die of anaemia, emanciation heart failure, reproductive disorders and inter-current bacterial infections that take advantage of the animals weakened resistance or suppressed immune system (Anosa, 1988; Horst 1996; Taylor and Authie 2004, Amadi et al., 2015) . Attempts to control trypanosomosis are based on large scale epidemiological studies, active detection and treatment of confirmed cases, combined with tsetse control programmes (Schofield and Kabayo, 2008) . Control programs concentrating on the eradication of vectors and drug treatment of infected people and animals have been in operation in some areas for decades (Bacchi, 2009) . The use of anti-trypanosomal drugs has been the most widely practised by means of controlling the disease in livestock, either by the use of curative or prophylactic drugs (Osuagwuh and Okore, 2014) . Diminazene aceturate (Berenil), isometamidium chloride (Trypamidium), and homidium salt (Ethidium), cymelarsan and suramin are the drugs commonly used for the treatment of African animal trypanosomiasis. Of these drugs, diminazene aceturate is the most commonly used therapeutic agent Leach and Roberts, 1981; Ogunyemi and Ilemobade, 1989; Delapeux and De Koning, 2007) while Levamisole is an antihelminthic agent with broad spectrum of activity. Levamisole has two types of clinical activity, first as an anthelminthic and as an immunomodulator (Symonens and Rosenthal, 1977) . But the ever increasing problem of resistance to hitherto effective antiparasitic agents in the last decade has added urgency to the need to discover new antiparasitic agents and to make better use of existing ones (Edward and Krishna, 2004) . It is therefore conceivable that combined administration of trypanocides with agents known to have immunostimulatory effects may enhance their therapeutic activity and efficacy (Adieme et al., 2014) and probably delay the relapse of the infection.
MATERIALS AND METHODS

Experimental Animals
Thirty adult albino mice were used in this study. This comprised of 25 males and 5 females. They were housed in the experimental animal house of the Department of Veterinary Medicine. They were acclimatized for two weeks before the commencement of the experiment during this period and throughout the duration of the experiment, they were fed with commercially produced poultry feed (Pelletized grower feed Vital feed®) and water was given ad libitum.
Infection of Experimental Mice
Trypanosoma brucei brucei was used in this work and was obtained from the blood of diagnosed slaughtered pigs at the Nsukka abattoir and maintained by passage in donor albino mouse. The donor mouse was bled by cardiac puncture. The infected blood was seri-ally diluted with normal saline. Each mouse was then infected with a total of 1X10 5 trypanosomes in 0.4ml of saline diluted infected mouse blood, intraperitoneally, after proper restraint.
Experimental Design
The 30 mice used for this experiment were divided into 6 groups (A-F) of 5 mice each. Group A consists of the infected mice and treated with DA (7mg/kg) and Levamisole (7.5mg/kg), group B consists of the mice infected and treated with DA (14mg/kg) and Levamisole (7.5mg/kg), group C contains the infected and treated with DA (21mg/kg) and Levamisole (7.5mg/kg), group D contains the infected and treated with Levamisole(7.5mg/kg), group E contains the infected but untreated (Positive control) and finally group F contains uninfected and untreated (negative control).
Drugs Diaminazine Aceturate manufactured by Pantex Holland Vet. Pharmaceutical products were used for this experiment. After reconstitution it was administered intraperitoneally as a single dose. Levamisole produced by Eagle Chemical Company Limited, Korea at the dose of 7.5mg/kg body weight was used in this study. After reconstitution, the drug was administered subcutaneously as a single dose.
Parameters for Assessing Comparative Drug Effects Parasitaemia
Blood was collected from the tail vein for parasite detection using Wet mount technique and the level of parasitaemia was estimated using standard procedures described by Herbert and Lumsden, (1976) . The blood collected from these Albino mice was examined daily post infection (PI) and post treatment to establish the onset of parasitaemia and parasite clearance time.
Body weight
The mice were weighed using electronic weighing balance and their weights recorded in grams (g). This was done on a weekly basis throughout the duration of the experiment.
Rectal temperature
The rectal temperatures of the mice were taken in the mornings on a weekly basis throughout the duration of the experiment. The values were recorded in degree Celsius ( o C).
Haematological studies
Blood samples about 1-2mls were collected from each Albino mice through the tail vein using micro-haematocrit capillary tubes into 21 different sterile vials containing anticoagulant, ethylene diamine tetracetate (EDTA) for hematological analysis. The following indices were determined using routine laboratory methods. Packed cell volume (PCV) as described by Schalm et al., (1975) ; Baker and Silverton (1982) and Dacie and Lewis (1991) . The PCV values were recorded as percentage (%). Haemoglobin concentration was determined using cyanomethaemoglobin method using the standard procedures described by Tiez, (1976) and Coles, (1986) . The haemoglobin concentration values were recorded in grams per decilitre (g/dl). The determination of hematological parameters was done pre infection, at the peak of parasitaemia and post treatment.
Survivability and Clinical signs
The mice were observed carefully throughout the experiment and individual deaths were recorded. The survivability of the mice was determined by calculating the dif-ference between the day of the onset of infection and the day each mouse died. Clinical signs of the infected mice were also observed and recorded.
Statistical Analysis
The data were collected and subjected to descriptive statistics, to obtain means and standard deviations of mean. The results of this study were statistically analyzed using Analysis of Variance (ANOVA).
RESULTS
Onset of Infection
All the infected mice became parasitaemic from day 4 to 5 PI. During this period, the parasites continued to multiply and the level of parasitaemia persistently increased. Sequel to this treatment which was administered by the 8th day PI to mice in groups A-D at the peak of parasitaemia. All the mice in the positive control (group E) died between days 42 and 65 PI.
Clinical signs
The clinical signs observed in the infected groups throughout the experiment were anaemia, anorexia, cachexia, depression, dullness, reluctance to move, starry hair coat, weakness, paleness of the mucous membrane and pyrexia. Following treatment, these signs gradually disappeared in the treated groups, while deaths were recorded in the infected untreated group (E).
Parasitaemia
Results of daily estimation of parasitaemia were shown in Table 1 . All the mice became parasitaemic by the 5th day PI and their level increased continually until the 8th day PI, when the albino mice in groups A to D were treated. In group A, treated with 7mg/kg body weight of DA and 7.5mg/kg body weight of Levamisole, the parasites cleared from the blood of two mice by 1½ days post treatment, and by 2days post treatment, aparasitaemia occurred in the remaining three mice in the group. Relapse infection occurred in one of the mice by day 34 post treatment, while the other four did not relapse until the 70th day post treatment, when the experiment was terminated. In group B, treated with 14mg/kg body weight of DA and 7.5mg/kg body weight of Levamisole, one mouse died on the 3rd day post treatment that is 11th day PI. By 1½ days post treatment, the remaining four mice were aparasitaemic and no relapse infection until day 70 post treatment, which is the end of the experiment. In group C, treated with 21mg/kg body weight of DA and 7.5mg/kg body weight of Levamisole, one mouse died on the 15th day PI that is day 1 post treatment, other deaths in this group occurred by days 24 and 50 post treatment.
In group D, treated with 7.5mg/kg body weight of Levamisole only, the parasite load persisted. One mouse died on the 10th day post treatment, second mice died on the 32nd day post treatment, a third on the 38th day post treatment and the remaining two mice died on the 42nd day post treatment. In group E, the infected but untreated group, one of the mice died on the 35th day post treatment, two died on the 46th day post treatment, another one died on the 52nd day post treatment, while the last one died on the 53rd day post treatment. Finally, in group F, the uninfected untreated group, there was no parasitaemia. Results of weekly estimation of body weight were shown in Figure 1 . There was no significant difference (p>0.05) in the mean body weights from the 1st week post infection to the 4th week post treatment. By the 5th week post treatment, only group D differed significantly (p<0.05) in mean body weights, when compared to other treated groups and the uninfected untreated group. On the 6th and 7th weeks post treatment, only group E (infected but untreated) was significantly different (p<0.05) in mean body weights, when compared to other groups. From the 8th to 10th week post treatment, the body weight did not indicate any significant difference (p>0.05) in all the groups.
Results of weekly mean rectal temperature was shown in Figure 2 . The mean rectal temperature of all the groups did not show any significant difference (p<0.05) from the 1st week post infection to the 3rd week post treatment. By the 4th week post treatment, there was no significant difference (p<0.05) in the mean rectal temperatures of all the groups, when compared to the uninfected untreated group (F). On the 5th and 6th weeks post treatment, the mean rectal temperatures of the combined treatment groups (A, B and C) differed significantly (p<0.05), when compared to that of the uninfected untreated group (F). At the 7th week post treatment, there was a significant increase (p>0.05) in the mean rectal temperature of group E (infected but untreated), and the treated group also showed a significant difference (p<0.05) in the mean temperatures, when compared to that of the uninfected untreated group (F). By the 8th and 9th weeks post treatment, the mean rectal temperature of the combined treatment groups (A, B and C) were significantly different (p<0.05), when compared to that of uninfected untreated group (F). At the 10th week post treatment, the mean rectal temperature of all the groups (both treated and uninfected untreated) did not differ significantly (p>0.05) till the end of the experiment. different superscripts in a row indicate significant difference between the mean packed cell volumes of the group (p<0.05). Table 2 shows the results of weekly estimation of PCV. Before onset of the infection, there was a significant difference (p<0.05) between the mean PCV of groups A, B and E when compared to that of groups C, D and F. By the 1st and 2nd weeks post infection, there was reduction in the mean PCV of all the infected groups (A-E), which differed significantly (p<0.05) from that of uninfected untreated group (F).
From the 1st to 7th post treatment, there was significant (P<0.05) decrease between the mean PCV of group D and E (single treatment and infected untreated groups), and those of groups A, B, C and F (combined treatment and uninfected untreated groups). By the 8th week post treatment, the mean PCV of the combined treatment groups (A, B and C) were significantly different (p<0.05), when compared to that of the uninfected untreated group (F) and this continued till the end of the experiment.
The weekly mean values of hemoglobin concentration were shown in Table 3 . There was significant difference (p<0.05) in the mean hemoglobin concentration of the infected groups (A-E) before infection, when compared to that of group F (uninfected untreated group). By the 1st week PI, there was no significant difference (p<0.05) in the mean hemoglobin concentration of all the groups. At the 2nd week PI, there was significant difference (p<0.05) between the mean hemoglobin concentration of the infected groups (A-E) and the uninfected untreated group (F). By the 1st week post treatment, only group E (infected but untreated) was significantly different (p<0.05) from that of the treated groups (A-D) and the uninfected untreated group (F). From the 2nd week post treatment, there was signif-icant reduction in the mean hemoglobin concentration of groups D and E (single treatment and infected untreated groups), and these significantly differed (p<0.05) from that of the uninfected untreated group (F). From the 2nd to 5th week post treatment, there was significant difference (p<0.05) between the mean haemoglobin concentration of the combined treatment groups (A, B and C), when compared to that of the uninfected untreated group (F). By the 6th week post treatment, there was no significant difference (p>0.05) between the mean hemoglobin concentrations of the combined treatment groups and that of the uninfected untreated group. On the 7th and 8th week post treatment, only group B which were treated with 14mg/kg body weight of DA and 7.5mg/kg body weight of Levamisole, differed significantly (p<0.05) from that of the uninfected untreated group. Finally, by week 9 and 10 post treatment, the mean hemoglobin concentrations (HbC) of the combined treatment groups (A, B and C) did not show any significant difference (p>0.05), when compared to that of the uninfected untreated group (F).
DISCUSSIONS
The parasites appeared in the blood stream 4 to 5 days post infection agreeing with previous work by Ihedioha et al., (2010) ; Adieme et al., (2014) ; Osondu et al., (2016) . The clinical signs observed in the mice, such as: anemia, anorexia, rough hair coat, emaciation, dullness, depression, pyrexia and pale mucous membrane were similar to those reported in Trypanosoma brucei brucei infection in mice, dogs, rabbits and goats by Anene et al.,(1999b); Ezeokonkwo and Agu, (2004) ; Amadi et al.,(2015) . However, these clinical signs disappeared shortly after treatment with the trypanocide and immunostimulator agreeing with the reports of Adieme et al., (2014) .
By the 48th hour post treatment, it was noticed that aparasitaemia occurred in the combined treatment groups A, B and C (treated with graded of DA and fixed doses of Levamisole) , when compared to group D (treated with levamisole alone), where the parasitaemia was persistent in the blood. This shows that in the combined treated groups DA achieved a very fast optimal therapeutic blood level and activity with Levamisole. In group E (infected but treated), there was significant reduction (p<0.05) in PCV and Hemoglobin concentration (HbC) values. This indicated severe anemia, as a result of the persistence of the parasites in their blood; hence death followed and this agrees with previous works done by Anosa et al., (1992) .
In group F (uninfected and untreated), there was progressive weight due to ad libitum feeding but in the infected groups, a decrease in the mean body weight was recorded and this is believed to be associated with anorexia and has also been reported in previous works by Fiennes, (1954) ; Anika et al., (1987) ; Adieme et al., (2014) . However following treatment, there was gradual increase in the mean body weight of the combined treatment groups (A, B and C), but a gradual decrease in the mean body weight of the single treatment group (D), when compared to that of uninfected untreated group (F). Increase in the mean body weight was due to increased appetite, aparasitaemia and subsequent disappearance of clinical signs following combined treatment with DA and Levamsole. This was not recorded in group D (treated with Levamisole alone), because of the persistence of the parasites in the blood.
There was increase in the mean rectal temperatures of groups D and E (treated with Levamisole only and infected untreated groups) and this differed significantly (p<0.05), when compared to that of uninfected untreated group (F). This may be due to stimulation of the thermoregulatory centre of the hypothalamus by the pyrogens (trypanosomes) and this temperature increase agrees with the work done by Losos and Ikede, (1972) ; Anika et al., (1987) and Anene et al., (1989) . In the combined treatment group (A, B and C), there was gradual increase in the mean rectal temperatures. By week 2, 7, 8 and 9 weeks post treatment, the fluctuating temperatures recorded agrees with previous work done by Ford, (1971) . This fluctuating temperature is a cardinal feature of trypanosomosis in animals generally but in the uninfected untreated group, recorded a normal mean rectal temperature, because the parasites were absent in the bloodstream of the mice.
Anaemia, another prominent feature of animal trypanosomosis (Anosa, 1983; Taylor and Authie, 2004) was evident in this work, as there was significant reduction (p<0.05) in the mean PCV and HbC values of all the combined treatment groups (A, B and C) which had recovered from the anemia that resulted from the infection and the parameters (PCV and HbC) compared favorably with that of the uninfected untreated group (F). In the group treated with Levamisole only (D), the anemia persisted and the hematological parameters differed significantly (p<0.05) when compared to those of the combined treatment and uninfected untreated groups. Again, by the 5th week post treatment, the mean PCV and HbC values of the combined treatment groups (A, B and C) started decreasing, before an increase, which lasted until the end of the work by week 10 posttreatment. This decrease might be attributed to a decreased drug activity and resurgence of the parasites from the brain, where they were protected from the effect of the trypanocide. The hematological parameters (PCV and HbC) for the infected but untreated group (E) decreased continuously, until the death of the mice, this agrees with previous works by Abenga et al., (2005) ; Ihedioha et al., (2010); Allam et al., (2011) . This was due to the persistence of the parasites in their bloodstream and these values differed significantly (p<0.05) from that of the uninfected untreated group (F).
Relapse infection was recorded in 20% of mice in group A (treated with 7 mg/kg body weight of DA and 7.5mg/kg body weight of Levamisole) by the 34th day post treatment. Relapse infection has been reported in previous works (Sutherland et al., 1992; EgbeNwiyi and Antia, 1996; Anene et al., 1999a; Gall et al., 2004) . Relapse could be attributed to sequestration of the parasites in the brain and the development of drug resistance (Jennings et al., 1977) . It has also been shown that DA molecules are too large to cross the blood brain barrier (Jennings et al., 1980) .
CONCLUSIONS
The result of this study has shown the therapeutic and immunostimulatory effects of DA and Levamisole respectively in the treatment of Trypanosoma brucei brucei infected albino mice. This is true for groups A, B and C (treated with graded doses of DA and fixed doses of Levamisole). However, in group A, relapse infection was recorded in one of the mice. In group B, no relapse occurred, but death of a mouse was recorded. Relapse infection in this work could be attributed to the decreased activity of both drugs, whereas death could be associated with the toxic effect of both drugs at a high dose.
It could be inferred from the results of this study, that a combined treatment with DA and levamisole was better than a single treatment with Levamisole, since the infection persisted in this group (D). Again, in the combined treatment group B (treated with a higher dose of DA 14mg/kg body weight and 7.5mg/kg body weight of Levamisole) gave the best results.
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